NewsSource: EClinCloud official website historical archive

EClinCloud and CR Medicon Partner to Support Digital Clinical Research Operations

4 min readEClinCloud Editorial Team
Archive article cover: EClinCloud partners with Ximaidi to support enterprise digital clinical research operations

On May 24, 2021, EClinCloud Technology Co., Ltd. ("EClinCloud") and Nanjing CR Medicon Pharmaceutical Technology Co., Ltd. ("CR Medicon"), a clinical contract research organization (CRO) under Pharmaron Clinical, jointly announced a partnership under which EClinCloud will support CR Medicon in building a digital operational management system for clinical research.

CR Medicon is a wholly owned subsidiary of Pharmaron Clinical and an emerging provider of comprehensive clinical services. As its business grows rapidly, CR Medicon will deploy the Clinical Trial Management System (CTMS) on EClinCloud's clinical evidence support platform. EClinCloud's CTMS features a user-friendly interface and flexible configuration tailored to client needs. Its clear, concise dashboards and reporting functions give project management teams immediate visibility into study status, enhancing project visibility and control. It also provides streamlined monitoring visit workflows, built-in monitoring report templates, and role-based notifications to improve monitor efficiency and satisfaction. Through EClinCloud's CTMS solution, CR Medicon will be able to effectively advance the digital operational management of its clinical research workflows, maintain real-time oversight of operations across all company projects, optimize internal operational efficiency, and accelerate overall clinical trial timelines.

Commenting on the partnership, Zhang Hai, Vice President of Clinical Operations at Pharmaron, said: "Amid the digital transformation and upgrading of clinical research in the post-pandemic era, CR Medicon places strong emphasis on informatization, digitalization, and intelligent capabilities in clinical research, particularly on clinical trial process management and data quality improvement. Through this partnership, we hope to leverage EClinCloud's integrated platform to help CR Medicon accelerate its digital transformation and improve clinical operational efficiency in a better and more standardized manner, thereby accelerating product launch timelines to benefit patients."

Dr. Qin Long, General Manager of EClinCloud, stated: "EClinCloud has long been committed to helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency and accelerate the market entry of drugs and medical devices through technological innovation and precision medical evaluation systems. Through this partnership, CR Medicon will become one of the first CRO clients to adopt our CTMS platform. We will provide CR Medicon with more flexible, customized solutions and are dedicated to delivering the highest-quality one-stop clinical trial service solutions to further optimize study operations, accelerate study timelines, and reduce costs and risks."

About EClinCloud

Guided by its mission of "bringing effective treatments to patients through technological innovation," EClinCloud is a healthcare and life-sciences technology company based in China and serving global markets. Through its seamlessly integrated end-to-end platform (covering scale management, linguistic validation, study design, eCOA, EDC, CTMS, eTMF, and more) and precision medical evaluation systems across therapeutic areas (including oncology, neurology, cardiology, pulmonology, dermatology, and others), EClinCloud builds a globally leading, patient-centric, integrated SaaS cloud platform for clinical evidence support, helping well-known domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market entry of drugs and medical devices, and benefit countless patients. For more information, please visit: www.eclincloud.com

About CR Medicon

Nanjing CR Medicon Pharmaceutical Technology Co., Ltd. is a wholly owned subsidiary of Pharmaron (stock codes: 300759.SZ/3759.HK), dedicated to providing clients with a drug & medical device clinical research service platform encompassing full-spectrum clinical development services, including regulatory affairs, medical strategy, medical writing, medical monitoring, pharmacovigilance, clinical operations, data management and statistical analysis, and bioanalysis. Since its founding more than three years ago, the company has provided high-quality, reliable clinical development services to nearly 200 pharmaceutical clients worldwide. Upholding a service ethos of professionalism, rigor, and efficiency, CR Medicon integrates high-quality service resources and systems to help clients reduce R&D risks, save R&D costs, and advance new products to market rapidly and efficiently. For more information, please visit www.crmedicon.com

About Pharmaron

Pharmaron (stock code: 300759.SZ / 3759.HK) is a leading international life sciences R&D services company. Since its founding in 2004, Pharmaron has been committed to talent development and facility construction, building an R&D service system spanning fields including synthetic and medicinal chemistry, biology, drug metabolism and pharmacokinetics, pharmacology, drug safety assessment, radiochemistry and radiolabeled metabolism, clinical pharmacology, clinical analytical sciences, clinical CRO and SMO, and API and drug product process development and manufacturing services. Operating in China, the United States, and the United Kingdom with more than 11,000 employees, Pharmaron provides R&D solutions to partners in North America, Europe, Japan, and China and maintains strong collaborative relationships with them.

Related reading

Cover image for archived article: National Innovation Center adopts EClinCloud CTMS and eTMF systems to digitally enable medical device clinical trialsNews3 min readNational Innovation Center for Advanced Medical Devices Adopts EClinCloud CTMS and eTMF Systems to Digitally Enable Medical Device Clinical TrialsOn October 14, EClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") attended the High-End Medical Device Clinical Trials Symposium and Clinical Trial Project Management System Launch Meeting, hosted by the National Innovation Center for Advanced Medical Devices ("the Center"). At the meeting, EClinCloud CEO Dr. Qin Long introduced the clinical trial project management system.Archived article cover: EClinCloud eTMF system supporting Yuanxin Technology in conducting an international multicenter clinical studyNews3 min readEClinCloud eTMF System Supports Biotyx Medical's International Multicenter Clinical StudyEClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") and Biotyx Medical (Shenzhen) Co., Ltd. ("Biotyx Medical") recently announced a deeper collaboration, under which Biotyx Medical is adopting EClinCloud's eTMF (electronic Trial Master File) solution for its international multicenter clinical trial of a below-the-knee bioresorbable scaffold. Using its digital management platform and extensive experience, EClinCloud supports Biotyx Medical's global business development needs to help it become a globally leading cardiovascular medical device company.Archived article cover: EClinCloud completes tens of millions of RMB in Series A financing to accelerate building its clinical evidence support platformNews3 min readEClinCloud Completes Tens of Millions of RMB in Series A Financing to Accelerate Its Clinical Evidence Support PlatformEClinCloud Technology Co., Ltd. ("EClinCloud") recently announced the completion of tens of millions of RMB in Series A financing, exclusively invested by Kangjun Capital. The proceeds will primarily be used to further strengthen its R&D, medical, clinical operations, and clinical data science teams, accelerate the realization of a patient-centric integrated cloud platform, and enhance after-sales service capabilities.